Quarterly report · Q1
7745.TEDINET S100OYU3
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.0bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥51.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.5bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | −¥219m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥847m | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | −¥1m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥5.6bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥956m | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥6m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥957m | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥159m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.6bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥570m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥153m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥698m | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥64.5bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥59.2bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥53.9bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥33.5bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥32.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥31.1bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥27.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥23.6bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥13.7bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.9bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-5.83 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.92 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.64 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥172.66 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.58 | 2021-04-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 47.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.9% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 97
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥6.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥6.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥1.6bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥18m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥102m |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥116m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥917m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥175m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.5bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥132m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.3bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥124m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥231m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥230m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥10m |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥131m |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥4.1bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥3.1bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | −¥15m |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥4.1bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.6bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥652m |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥322m |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥7.6bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥5.7bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥272m |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥10.1bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥5.1bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥792m |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥322m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥4.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥4.7bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥294m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥875m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥822m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥52m |
| jpcrp040300-q1r_E02344-000America Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥81m |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.8bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.8bn |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥3m |
| jpcrp040300-q1r_E02344-000America Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥45m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.0bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥606m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥117m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.7bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥166m |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02344-000Asia And Oceania Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥8m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥212m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥212m |
| jpcrp040300-q1r_E02344-000Europe Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥0 |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.7bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.7bn |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥4m |
| jpcrp040300-q1r_E02344-000Europe Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥130m |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥3.9bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥3.3bn |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥587m |
| jpcrp040300-q1r_E02344-000Japan Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | −¥184m |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥3.1bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.9bn |
| jpcrp040300-q1r_E02344-000Japan Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥535m |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Japan Semiconductor Relatedreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥407m |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥6.6bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥5.4bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Measuring Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥14m |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥8.3bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥4.9bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥3.4bn |
| jpcrp040300-q1r_E02344-000Medical And Health Systemreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥720m |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E02344-000Semiconductor Related Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥407m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 450
| Item | Context | Value | Unit |
|---|---|---|---|
| Selling general and administrative expenses | Prior1YTDDuration | 4364000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 4596000000 | JPY |
| Operating income | Prior1YTDDuration | 847000000 | JPY |
| Operating income | CurrentYTDDuration | -219000000 | JPY |
| Interest income noi | Prior1YTDDuration | 13000000 | JPY |
| Interest income noi | CurrentYTDDuration | 48000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 27000000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 171000000 | JPY |
| Subsidy income noi | Prior1YTDDuration | 116000000 | JPY |
| Subsidy income noi | CurrentYTDDuration | － | JPY |
| Land and house rent received noi | Prior1YTDDuration | 9000000 | JPY |
| Land and house rent received noi | CurrentYTDDuration | 12000000 | JPY |
| Other noi | Prior1YTDDuration | 27000000 | JPY |
| Other noi | CurrentYTDDuration | 42000000 | JPY |
| Non operating income | Prior1YTDDuration | 195000000 | JPY |
| Non operating income | CurrentYTDDuration | 274000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 33000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 44000000 | JPY |
| Settlement package noe | Prior1YTDDuration | 44000000 | JPY |
| Settlement package noe | CurrentYTDDuration | － | JPY |
| Other noe | Prior1YTDDuration | 7000000 | JPY |
| Other noe | CurrentYTDDuration | 11000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 85000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 55000000 | JPY |
| Ordinary income | Prior1YTDDuration | 956000000 | JPY |
| Ordinary income | CurrentYTDDuration | -1000000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 1000000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 0 | JPY |
| Extraordinary income | Prior1YTDDuration | 1000000 | JPY |
| Extraordinary income | CurrentYTDDuration | 0 | JPY |
| Loss on sales of noncurrent assets el | Prior1YTDDuration | 0 | JPY |
| Loss on sales of noncurrent assets el | CurrentYTDDuration | 0 | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration | 0 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 0 | JPY |
| Loss on valuation of investment securities el | Prior1YTDDuration | － | JPY |
| Loss on valuation of investment securities el | CurrentYTDDuration | 4000000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 0 | JPY |
| Extraordinary loss | CurrentYTDDuration | 5000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 957000000 | JPY |
| Income before income taxes | CurrentYTDDuration | -6000000 | JPY |
| Income taxes current | Prior1YTDDuration | 240000000 | JPY |
| Income taxes current | CurrentYTDDuration | 205000000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 17000000 | JPY |
| Income taxes deferred | CurrentYTDDuration | -57000000 | JPY |
| Income taxes | Prior1YTDDuration | 258000000 | JPY |
| Income taxes | CurrentYTDDuration | 147000000 | JPY |
| Profit loss | Prior1YTDDuration | 698000000 | JPY |
| Profit loss | CurrentYTDDuration | -153000000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 128000000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 6000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |